Trials / Completed
CompletedNCT00137371
Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 480 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 45 Years – 80 Years
- Healthy volunteers
- —
Summary
This protocol is designed to study the effect and safety of 2 low-dose regimens of conjugated estrogen cream (PVC) given vaginally in postmenopausal women with atrophic vaginitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PVC (daily for 21 days, 7 days off) | |
| DRUG | PVC (twice weekly) |
Timeline
- Start date
- 2005-08-01
- Completion
- 2007-09-01
- First posted
- 2005-08-29
- Last updated
- 2007-12-10
Locations
49 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00137371. Inclusion in this directory is not an endorsement.